Showing results (781-790 of 816) with videos related to
Sort By:
Pageof 82
British Journal of Haematology|July 18, 2015
Optimizing the management of patients with spinal myeloma diseaseSean Molloy, Maggie Lai, Guy Pratt, et al.Alzheimer'S Research & Therapy|December 3, 2025
Individualized prediction of clinical progression to dementia using plasma biomarkers in non-demented elderlyMadison I J Honey, Ingrid S van Maurik, Argonde C van Harten, et al.Antimicrobial Agents and Chemotherapy|April 18, 2012
Evaluation of arylimidamides DB1955 and DB1960 as candidates against visceral leishmaniasis and Chagas' disease: in vivo efficacy, acute toxicity, pharmacokinetics, and toxicology studiesXiaohua Zhu, Qiang Liu, Sihyung Yang, et al.Science Translational Medicine|May 1, 2020
Discovery and pharmacological characterization of AZD3229, a potent KIT/PDGFRα inhibitor for treatment of gastrointestinal stromal tumorsErica Banks, Michael Grondine, Deepa Bhavsar, et al.The Journal of Clinical Investigation|October 31, 2017
Pharmacological inhibition of the transcription factor PU.1 in leukemiaIléana Antony-Debré, Ananya Paul, Joana Leite, et al.Nature Communications|July 12, 2019
Decreased maternal serum acetate and impaired fetal thymic and regulatory T cell development in preeclampsiaMingjing Hu, David Eviston, Peter Hsu, et al.Alzheimer'S Research & Therapy|August 21, 2024
Rationale and design of the BeyeOMARKER study: prospective evaluation of blood- and eye-based biomarkers for early detection of Alzheimer's disease pathology in the eye clinicIlse Bader, Colin Groot, H Stevie Tan, et al.JAMA Oncology|January 6, 2022
Comparison of Prophylactic Intravenous Antibiotic Regimens After Endoprosthetic Reconstruction for Lower Extremity Bone Tumors: A Randomized Clinical Trial, Michelle Ghert, Patricia Schneider, et al.European Radiology|June 8, 2018
Clinical indications for musculoskeletal ultrasound updated in 2017 by European Society of Musculoskeletal Radiology (ESSR) consensusLuca Maria Sconfienza, Domenico Albano, Georgina Allen, et al.Journal of Medicinal Chemistry|July 2, 2013
2-[(3aR,4R,5S,7aS)-5-{(1S)-1-[3,5-bis(trifluoromethyl)phenyl]-2-hydroxyethoxy}-4-(2-methylphenyl)octahydro-2H-isoindol-2-yl]-1,3-oxazol-4(5H)-one: a potent human NK1 receptor antagonist with multiple clearance pathwaysAndrew J Kassick, Jinlong Jiang, Jaime Bunda, et al.Pageof 82